|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.12 USD | -0.12% |
|
-0.82% | +0.85% |
| 27/02 | Lumos Diagnostics Holdings Fiscal H1 Revenue Falls Slightly; Shares Up 3% | MT |
| 25/02 | ImpediMed Limited Appoints Erik Anderson as Independent Non-Executive Director, Effective 25 February 2026 | CI |
| Capitalization | 1.68TCr 1.47TCr 1.32TCr 1.27TCr 2.3TCr 1,55100Cr 2.4TCr 16TCr 6.27TCr 74TCr 6.29TCr 6.16TCr 2,67700Cr | P/E ratio 2026 * |
22.9x | P/E ratio 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise value | 1.65TCr 1.44TCr 1.3TCr 1.25TCr 2.27TCr 1,52700Cr 2.36TCr 16TCr 6.17TCr 73TCr 6.19TCr 6.06TCr 2,63500Cr | EV / Sales 2026 * |
3.9x | EV / Sales 2027 * | 3.49x |
| Free-Float |
74.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Hologic, Inc.
| 1 day | -0.12% | ||
| 1 week | -0.82% | ||
| Current month | -0.32% | ||
| 1 month | +0.11% | ||
| 3 months | +0.16% | ||
| 6 months | +16.56% | ||
| Current year | +0.85% |
| 1 week | 75.05 | 75.74 | |
| 1 month | 74.95 | 75.75 | |
| Current year | 74.49 | 75.75 | |
| 1 year | 51.9 | 75.75 | |
| 3 years | 51.9 | 87.88 | |
| 5 years | 51.9 | 87.88 | |
| 10 years | 26.49 | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 07/12/2013 | |
Karleen Oberton
DFI | Director of Finance/CFO | 56 | 01/08/2018 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/11/2011 | |
| Chairman | 62 | 16/06/2015 | |
| Director/Board Member | 71 | 15/05/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.12% | -0.82% | +23.74% | -5.34% | 1.68TCr | ||
| -2.32% | -7.49% | -11.05% | -16.47% | 17TCr | ||
| -1.48% | -3.67% | -2.53% | +100.68% | 17TCr | ||
| +0.57% | -4.18% | -11.11% | -23.50% | 13TCr | ||
| +0.85% | -3.11% | -28.85% | +43.10% | 10TCr | ||
| -0.64% | -4.03% | -25.77% | -22.13% | 4.95TCr | ||
| -3.31% | +0.21% | +18.07% | +4.62% | 4.75TCr | ||
| -0.68% | -8.71% | +2.98% | +10.69% | 3.35TCr | ||
| +0.63% | -4.71% | -13.66% | -8.26% | 3.23TCr | ||
| -0.11% | -3.09% | -7.98% | -19.43% | 3.15TCr | ||
| Average | -0.66% | -3.96% | -5.62% | +6.40% | 7.86TCr | |
| Weighted average by Cap. | -0.87% | -4.48% | -9.38% | +17.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423.56Cr 370.24Cr 334.49Cr 319.98Cr 581.98Cr 39TCr 604.97Cr 4TCr 1.58TCr 19TCr 1.59TCr 1.56TCr 68TCr | 445.92Cr 389.78Cr 352.14Cr 336.87Cr 612.71Cr 41TCr 636.91Cr 4.21TCr 1.67TCr 20TCr 1.67TCr 1.64TCr 71TCr |
| Net income | 74Cr 64Cr 58Cr 56Cr 101.2Cr 6.81TCr 105.2Cr 694.82Cr 275.35Cr 3.25TCr 276.37Cr 270.53Cr 12TCr | 84Cr 73Cr 66Cr 63Cr 114.77Cr 7.73TCr 119.31Cr 788.03Cr 312.29Cr 3.69TCr 313.45Cr 306.83Cr 13TCr |
| Net Debt | -26Cr -23Cr -21Cr -20Cr -36Cr -2.43TCr -38Cr -247.91Cr -98Cr -1.16TCr -99Cr -97Cr -4.19TCr | -122.38Cr -106.97Cr -97Cr -92Cr -168.15Cr -11TCr -174.79Cr -1.15TCr -457.53Cr -5.41TCr -459.23Cr -449.52Cr -20TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 75.12 $ | -0.12% | 42,05,647 |
| 12/26/12 | 75.21 $ | -0.27% | 26,06,466 |
| 11/26/11 | 75.41 $ | -0.17% | 18,59,191 |
| 10/26/10 | 75.54 $ | -0.07% | 30,66,471 |
| 09/26/09 | 75.59 $ | -0.20% | 23,38,386 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















